Bioengineered plants meet vaccines. It actually is a lot more promising than it may sound. A pioneer in the field is Arizona State University Professor Charles Arntzen. He has been working on nothing less than the world’s most promising anti-Ebola drug. ZMapp is an injectable synthetic serum made of genetically engineered antibodies grown in tobacco plants. The technology could be used to combat other infectious diseases and lower the cost of expensive drugs used to fight cancer, HIV, and other chronic health conditions. The story of Pr. Arntzen and his Ebola project reads like a thriller script. We hope you enjoy it as we have.
Meet Charles Arntzen, creator of world’s most promising anti-Ebola drug from tobacco plants
More of Today's Solutions
Elevate your tea experience: 5 innovative ways to improve your daily brew
While the classic simplicity of tea is always comforting, there's a world of flavors waiting to be explored. If you want to add some ...
Read MoreTransforming Tylenol: a sustainable path without coal tar or crude oil
Paracetamol, the omnipresent pain reliever found in countless households worldwide, may soon radically adjust its manufacturing method. For more than a century, this medicine, ...
Read MoreSuccessful gene-hacked pig kidney transplant shows promise in xenotransplanta...
A team at Massachusetts General Hospital in Boston performed a breakthrough surgical accomplishment, transplanting a kidney from a gene-hacked pig into a 62-year-old man. ...
Read MoreUSDA implements new school meal standards to reduce added sugars
The United States Department of Agriculture (USDA) announced significant changes to school meal laws, including the first time added sugars will be banned on ...
Read More
